CNTB
NASDAQ
US
Connect Biopharma Holdings Limited - Ordinary Shares
$2.99
▲ +$0.27
(+9.93%)
Vol 854K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$157.6M
ROE
-62.7%
Margin
-175.2%
D/E
0.00
Beta
-0.18
52W
$1–$3
Wall Street Consensus
11 analysts · Apr 20264
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
90.9%
Buy Rating
Price Chart
Similar Stocks
GALT
Galectin Therapeutics Inc
$268.2M
ACHV
Achieve Life Sciences Inc
$264.6M
SGMT
Sagimet Biosciences Inc
$183.5M
CNTN
Canton Strategic Holdings Inc
PRLD
Prelude Therapeutics Inc
$164.2M
ARTV
Artiva Biotherapeutics Inc
$105.3M
RNAC
Cartesian Therapeutics Inc
$187.5M
WHWK
Whitehawk Therapeutics Inc
$114.1M
NKTX
Nkarta Inc
$131.4M
ABOS
Acumen Pharmaceuticals Inc
$127.8M
Earnings
Beat rate: 80.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-1.44 | $-1.91 | $-0.47 |
| Sep 2025 | $-1.01 | $-0.31 | +$0.70 |
| Jun 2025 | $-0.92 | $-0.23 | +$0.69 |
| Mar 2025 | $-1.92 | $-0.19 | +$1.73 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -34.9% | -7.9% | -7.9% | -7.9% | -7.9% | -62.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -26872.9% | — | — | — | — | -175.2% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 7.24 | 11.46 | 11.46 | 11.46 | 11.46 | 5.48 |
Key Ratios
ROA (TTM)
-54.6%
P/S (TTM)
6.04
P/B
0.6
EPS (TTM)
$-0.82
52W High
$3.28
52W Low
$0.51
$0.51
52-Week Range
$3.28
How does CNTB compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
CNTB valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
6.0
▼
53%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.6
▼
74%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
CNTB profitability vs Biotechnology peers
ROE
-62.7%
▲
7%
above
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
-175.2%
▲
39%
above
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-54.6%
▼
17%
below
peers
(-46.7%)
vs Peers
vs Industry
Below avg
CNTB financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
5.5
▲
23%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
-0.2
▼
118%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
CNTB fundamentals radar
CNTB
Peer median
Industry
CNTB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CNTB vs peers: key metrics
Latest News
No related news yet